Tenaya Therapeutics (TNYA)
(Delayed Data from NSDQ)
$4.40 USD
+0.12 (2.80%)
Updated May 14, 2024 04:00 PM ET
After-Market: $4.40 0.00 (0.00%) 7:58 PM ET
3-Hold of 5 3
F Value B Growth C Momentum D VGM
Detailed Estimates
EPS Estimates
Exp Earnings Date | 5/15/24 |
---|---|
Current Quarter | -0.43 |
EPS Last Quarter | -0.40 |
Last EPS Surprise | 11.11% |
ABR | 1.00 |
Earnings ESP
|
0.00% |
---|---|
Current Year | -1.70 |
Next Year | -1.90 |
EPS (TTM) | -1.67 |
P/E (F1) | NA |
Sales Estimates
Current Qtr (3/2024) |
Next Qtr (6/2024) |
Current Year (12/2024) |
Next Year (12/2025) |
|
---|---|---|---|---|
Zacks Consensus Estimate | NA | NA | 5.00M | 11.50M |
# of Estimates | NA | NA | 1 | 2 |
High Estimate | NA | NA | 5.00M | 15.00M |
Low Estimate | NA | NA | 5.00M | 8.00M |
Year ago Sales | 0.00M | 0.00M | NA | 5.00M |
Year over Year Growth Est. | NA | NA | NA | 130.00% |
Earnings Estimates
Current Qtr (3/2024) |
Next Qtr (6/2024) |
Current Year (12/2024) |
Next Year (12/2025) |
|
---|---|---|---|---|
Zacks Consensus Estimate | -0.43 | -0.45 | -1.70 | -1.90 |
# of Estimates | 5 | 4 | 6 | 5 |
Most Recent Consensus | -0.43 | -0.47 | -1.80 | -1.74 |
High Estimate | -0.41 | -0.42 | -1.10 | -1.60 |
Low Estimate | -0.45 | -0.50 | -1.91 | -2.25 |
Year ago EPS | -0.43 | -0.45 | -1.68 | -1.70 |
Year over Year Growth Est. | 0.00% | 0.00% | -1.19% | -12.00% |
Agreement - Estimate Revisions
Current Qtr (3/2024) |
Next Qtr (6/2024) |
Current Year (12/2024) |
Next Year (12/2025) |
|
---|---|---|---|---|
Up Last 7 Days | 0 | 0 | 0 | 0 |
Up Last 30 Days | 0 | 0 | 0 | 0 |
Up Last 60 Days | 1 | 1 | 2 | 4 |
Down Last 7 Days | 0 | 0 | 0 | 0 |
Down Last 30 Days | 0 | 0 | 0 | 0 |
Down Last 60 Days | 0 | 1 | 3 | 1 |
Magnitude - Consensus Estimate Trend
Current Qtr (3/2024) |
Next Qtr (6/2024) |
Current Year (12/2024) |
Next Year (12/2025) |
|
---|---|---|---|---|
Current | -0.43 | -0.45 | -1.70 | -1.90 |
7 Days Ago | -0.43 | -0.45 | -1.70 | -1.90 |
30 Days Ago | -0.43 | -0.45 | -1.70 | -1.90 |
60 Days Ago | -0.45 | -0.49 | -1.70 | -2.13 |
90 Days Ago | -0.45 | -0.49 | -1.70 | -2.13 |
Upside - Most Accurate Estimate Versus Zacks Consensus
Current Qtr (3/2024) |
Next Qtr (6/2024) |
Current Year (12/2024) |
Next Year (12/2025) |
|
---|---|---|---|---|
Most Accurate Estimate | -0.43 | -0.45 | -1.70 | -1.90 |
Zacks Consensus Estimate | -0.43 | -0.45 | -1.70 | -1.90 |
Earnings ESP | 0.00% | 0.00% | 0.00% | 0.00% |
Surprise - Reported Earnings History
Quarter Ending (12/2023) |
Quarter Ending (9/2023) |
Quarter Ending (6/2023) |
Quarter Ending (3/2023) |
Average Surprise | |
---|---|---|---|---|---|
Reported | -0.40 | -0.39 | -0.45 | -0.43 | NA |
Estimate | -0.45 | -0.47 | -0.51 | -0.60 | NA |
Difference | 0.05 | 0.08 | 0.06 | 0.17 | 0.09 |
Surprise | 11.11% | 17.02% | 11.76% | 28.33% | 17.06% |
Quarterly Estimates By Analyst
Zacks Premium Subscription Required Learn more
Annual Estimates By Analyst
Zacks Premium Subscription Required Learn more